A simple scene from the clinic tells a bigger story. A patient asks why an AI tool reached a certain conclusion. The clinician pauses. The explanation is partial. The data trail is unclear. The moment passes, but the trust gap widens.
This is not necessarily a failure of intent. It is often a symptom of fragmented healthcare data and unclear data provenance.
Healthcare data can sit across multiple systems, organisations and platforms. Identifiers, timestamps and context may not always align. Provenance can be incomplete, consent may be recorded differently, and the quality of the data available to AI systems can vary.
When AI is built on fragmented or poorly understood data, it becomes harder to explain how information has been used and whether the right permissions and safeguards were in place.
The Challenge of Fragmented Healthcare Data
The challenge is not only the AI model itself. It is also the integrity of the data lifecycle that supports it.
To build confidence in healthcare AI, organisations need to understand what data was used, where it came from, under what consent, and what quality controls were applied. They also need a reliable way to understand how those conditions change over time.
This becomes increasingly difficult when data moves between different organisations and systems.
Policies and documentation remain important, but they are only part of the picture. Digital infrastructure can also help create clearer and more verifiable records of consent, access and provenance.
Consent, Provenance and Patient Ownership
Blockchain-based infrastructure can provide one approach to creating tamper-evident records of consent and data provenance.
The purpose is not to place clinical information itself on a public ledger. Instead, the technology can be used to record information about how data is accessed, when permission is granted or changed, and the conditions associated with that use.
Patient-controlled consent can make this process more transparent.
Rather than consent being treated as a one-off form or static administrative record, patients can potentially have greater visibility and control over how their information is used.
Clear provenance can also help organisations better understand the source and context of the data being used within AI systems.
BlockMed Pro’s Approach With One True Record
At BlockMed Pro, our approach centres on a patient-controlled model called the One True Record.
The concept is designed around giving individuals greater control over permissions relating to their health information, while creating clearer records around consent and data provenance.
This approach aims to make it easier to understand who has permission to access particular information, for what purpose, and under what conditions.
Rather than treating consent as something separate from the data lifecycle, the intention is to make it part of the infrastructure surrounding how health information is accessed and used.
For organisations exploring healthcare AI, this kind of consent and provenance layer may help create a clearer governance framework around the data being used.
What This Could Look Like in Practice
Consider a hypothetical scenario in which an NHS trust wants to validate an AI triage model using real-world data.
Traditionally, this may involve multiple approvals, data-sharing arrangements and processes for identifying which information can be used.
With a patient-controlled consent layer, the organisation could clearly communicate the purpose of the project, the safeguards involved and how data would be used.
Patients could then make an informed decision about whether to participate.
Where consent is provided, the relevant permissions and provenance information could remain associated with the authorised data. This could create a clearer audit trail for organisations reviewing how information has been accessed and used.
If permissions change, those changes could also be reflected within the consent framework.
For research and industry collaborations, BlockMed Pro’s Marketplace is designed around a more transparent and responsible approach to data access.
Building Trust Into Healthcare AI
For healthcare AI teams, stronger consent and provenance can support several important areas of governance.
Clearer data lineage can help teams understand where information originated. Provenance can provide additional context when reviewing datasets. Consent records can help clarify the conditions under which information is being used.
These factors can also support broader work around explainability, auditability and responsible data governance.
They do not remove the need for appropriate clinical, technical, regulatory and ethical oversight. Any claims relating to AI performance or clinical outcomes should still be assessed within the relevant study, validation and governance processes.
My reflection as a GP and builder is simple: trust cannot simply be added at the end of an algorithm.
It needs to be considered throughout the way data is collected, permissioned, accessed and used.
When patients have greater visibility and control over their information, and organisations can demonstrate clearer provenance and governance, healthcare AI can be developed on a more transparent foundation.
The future of healthcare AI will not depend on scale alone. It will also depend on whether patients, clinicians and organisations can understand and trust the way data is being used.
To learn more about BlockMed Pro’s approach to patient-controlled health information, explore the One True Record. For research and industry collaboration, visit the Marketplace, or learn more about BlockMed Pro.



